1. 665PNRF2 activation via PI3K/AKT/mTOR/RPS6 causes resistance to anti-HER2 agents among HER2 amplified gastric cancer. (23rd October 2018) Authors: Gambardella, V; Gimeno-Valiente, F; Tarazona, N; Fleitas Kanonnikoff, T; Tolosa, P; Belda Moscardò, M; Garcia-Mico, B; Huerta, M; Roselló, S; Roda, D; Cervantes, A; Castillo, J Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. LBA24A multi-omic analysis for prospective patient stratification in localised colorectal cancer (CRC). (23rd October 2018) Authors: Tarazona Llavero, N; Fontana, E; Gambardella, V; Gimeno-Valiente, F; Castillo, J; Calon, A; Martínez-Ciarpaglini, C; Peiró-Chova, L; Huerta, M; Zuñiga, S; Rentero-Garrido, P; Montón-Bueno, J; Roda, D; Roselló, S; Bellosillo, B; Vivancos, A; Nyamundana, G; Montagut, C; Sadanandam, A; Cervantes, A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Management of infusion reactions to systemic anticancer therapy: ESMO Clinical Practice Guidelines. (5th May 2018) Authors: Roselló, S; Blasco, I; García Fabregat, L; Cervantes, A; Jordan, K Journal: Annals of oncology Issue: Volume 29(2018)Supplement 4 Page Start: iv260 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Neoadjuvant score in locally advanced rectal cancer: integrating downstaging in risk assessment and looking for new valuable end points. (14th May 2018) Authors: Roselló, S; Cervantes, A Journal: Annals of oncology Issue: Volume 29:Number 7(2018) Page Start: 1493 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Targeted next-generation sequencing of circulating-tumor DNA for tracking minimal residual disease in localized colon cancer. (28th September 2019) Authors: Tarazona, N; Gimeno-Valiente, F; Gambardella, V; Zuñiga, S; Rentero-Garrido, P; Huerta, M; Roselló, S; Martinez-Ciarpaglini, C; Carbonell-Asins, J A; Carrasco, F; Ferrer-Martínez, A; Bruixola, G; Fleitas, T; Martín, J; Tébar-Martínez, R; Moro, D; Castillo, J; Espí, A; Roda, D; Cervantes, A Journal: Annals of oncology Issue: Volume 30:Number 11(2019) Page Start: 1804 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Towards precision oncology for HER2 blockade in gastroesophageal adenocarcinoma. (2nd May 2019) Authors: Gambardella, V; Fleitas, T; Tarazona, N; Cejalvo, J M; Gimeno-Valiente, F; Martinez-Ciarpaglini, C; Huerta, M; Roselló, S; Castillo, J; Roda, D; Cervantes, A Journal: Annals of oncology Issue: Volume 30:Number 8(2019) Page Start: 1254 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗